Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease
Adv Ther. 2025 Aug 28. doi: 10.1007/s12325-025-03328-y. Online ahead of print. ABSTRACT INTRODUCTION: We report the long-term safety of upadacitinib […]
